136 related articles for article (PubMed ID: 37890803)
1. Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K/Akt/NF-κB signaling pathway.
Xu Z; Cai K; Su SL; Zhu Y; Liu F; Duan JA
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117356. PubMed ID: 37890803
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway.
Zhang X; Li S; Chen Z; Liang W; Pei S; Gou F; Jia Z; Geng Z; Gong X
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37800602
[TBL] [Abstract][Full Text] [Related]
3. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
[TBL] [Abstract][Full Text] [Related]
4. Compound Danshen Dripping Pill ameliorates post ischemic myocardial inflammation through synergistically regulating MAPK, PI3K/AKT and PPAR signaling pathways.
Lei W; Li X; Li L; Huang M; Cao Y; Sun X; Jiang M; Zhang B; Zhang H
J Ethnopharmacol; 2021 Dec; 281():114438. PubMed ID: 34390798
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
6. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
7. Influence of LncRNA UCA1 on glucose metabolism in rats with diabetic nephropathy through PI3K-Akt signaling pathway.
Shi CH; Huang Y; Li WQ; Chen RG
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10058-10064. PubMed ID: 31799676
[TBL] [Abstract][Full Text] [Related]
8. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
9.
Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163
[No Abstract] [Full Text] [Related]
10. Tanshinone IIA down-regulates -transforming growth factor beta 1 to relieve renal tubular epithelial cell inflammation and pyroptosis caused by high glucose.
Li Y; Deng X; Zhuang W; Li Y; Xue H; Lv X; Zhu S
Bioengineered; 2022 May; 13(5):12224-12236. PubMed ID: 35577353
[TBL] [Abstract][Full Text] [Related]
11. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
12. [Tanshinone IIA alleviates monocrotaline-induced pulmonary hypertension in rats through the PI3K/Akt-eNOS signaling pathway].
Zhang X; Liu S; Sun Y; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):718-723. PubMed ID: 35673916
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
14. Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.
Nie Y; Fu C; Zhang H; Zhang M; Xie H; Tong X; Li Y; Hou Z; Fan X; Yan M
BMC Complement Med Ther; 2020 Oct; 20(1):321. PubMed ID: 33097050
[TBL] [Abstract][Full Text] [Related]
15. Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments.
Heo JY; Im DS
Int Immunopharmacol; 2019 Feb; 67():69-77. PubMed ID: 30537633
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
[TBL] [Abstract][Full Text] [Related]
19. [Yiqi Yangyin Tongluo Recipe(YYTR)alleviates renal injury in diabetic nephropathy rats by inhibiting PI3K/AKT pathway and aquaporin 2 (AQP2)].
Yu R; Lu Z; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Feb; 38(2):138-145. PubMed ID: 35356882
[TBL] [Abstract][Full Text] [Related]
20. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
